1
Clinical Trials associated with CMVpp65 Specific T-cells(Memorial Sloan Kettering Cancer Center)A Phase II Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
The purpose of this study is to see how well transfusions of T-cells work in treating CMV. Tcells are a type of white blood cell that helps protect the body from infection. A transfusion is the process by which blood from one person is transferred to the blood of another. In this case, the T-cells are made from the blood of donors who are immune to CMV. The T-cells are then grown and taught to attack the CMV virus in a lab.
100 Clinical Results associated with CMVpp65 Specific T-cells(Memorial Sloan Kettering Cancer Center)
100 Translational Medicine associated with CMVpp65 Specific T-cells(Memorial Sloan Kettering Cancer Center)
100 Patents (Medical) associated with CMVpp65 Specific T-cells(Memorial Sloan Kettering Cancer Center)
100 Deals associated with CMVpp65 Specific T-cells(Memorial Sloan Kettering Cancer Center)